We are dedicated to acquiring and providing strategic resources and expansion capital to innovative healthcare companies that strive to provide much needed healthcare and related products to patients in need. By partnering with exceptional entrepreneurs we aim to help to create market-leading products in the biomedical and healthcare sector. As entrepreneurs and investors with operational and technical expertise we embrace a collaborative approach to capital formation and business development.
See and hear How we Tell Our Corporate Story
ABOUT QBIO by OUR CEO
QUARTERLY & ANNUAL REPORTS
PRESS AND NEWS
Q BioMed Takes the Stage in the Expanded Access Debate at European Early and Managed Access Program Conference
Q BioMed Orphan Drug VP, who started the first Expanded Access Program Database asked to Speak on Panels and run Roundtable at the Early and Managed Access Program Conference in the UK from October 22nd to 24th 2018 NEW YORK, October 26, 2018 /PRNewswire/ -- Q BioMed...
Q BioMed Provides Important Update on QBM001 Developmental Drug Targeting a Non-Verbal and Minimally Verbal Patient Subset on the Autism Spectrum
Company Further Develops Its Autistic Spectrum Disorder (ASD) Drug Technology and Expects Several Development Partnerships In Anticipation of Clinical Program in 2019NEW YORK, October 9, 2018 /PRNewswire/ --Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration...
Financing Provides Necessary Capital to Reach Important MilestonesNEW YORK, September 24, 2018 /PRNewswire/ --Q BioMed Inc. (OTCQB: QBIO), is pleased to announce that it has entered into a definitive agreement with Yorkville Advisors Global ('Yorkville') for...
SEE OUR REPORTS AND FILINGS
Copyright © 2018 Q BioMed, Inc. All Rights Reserved
501 Madison Ave, 14th Floor
New York, NY 10022 USA
P: +1 888 357 2435